Comparison of Clinical Characteristics and Outcomes of Peripartum Cardiomyopathy Between African American and Non–African American Women

Authors:

Abstract
Peripartum cardiomyopathy (PPCM) is an often devastating form of maternal systolic heart failure that occurs toward the end of pregnancy or in the months after delivery in the absence of a clear cause or preexisting heart disease.1-3 Previous research has suggested that PPCM is hormonal and vascular in origin.4-6 In addition, recent work has revealed the frequent occurrence in women with PPCM of mutations in the large sarcomeric gene titin (TTN) (OMIM 188840), supporting a strong role for genetics in PPCM.7 Consistent with a genetic contribution to PPCM, several studies8-10 have also suggested that women of African ancestry are disproportionately affected by PPCM and face a worse prognosis. Overall, however, small sample sizes and limited access to medical records have limited the detailed understanding and the generalizability of clinical outcomes between African American and non–African American women. We leveraged the high prevalence of PPCM in the University of Pennsylvania Health System (UPHS), and particularly of women of African ancestry who had PPCM, to explore clinical characteristics at presentation and outcomes in a cohort of 220 women with PPCM, including 121 African American women, who are to our knowledge the largest such cohort to date.